Sea You at Fetch Long Beach
Logo Image
|Videos|August 31, 2021

Addressing therapeutic needs in veterinary health

Anivive Lifesciences Inc Founder, CEO and Chairman Dylan Balsz discussed the company’s mission and how it is working to serve unmet needs in veterinary health.

Anivive Lifesciences Inc Founder, CEO and Chairman Dylan Balsz discussed the veterinary drug development company’s mission and how it is working to serve unmet needs in animal health, during an interview with dvm360®at the Fetch dvm360® Conference in Kansas City, Missouri.

View the video for the full statement. The following is a partial transcript:

Dylan Balsz: Specialty medicine and veterinary pharma can only get so far if the treatments aren’t affordable and broadly available. And, so, with our cancer therapy, we’ve been able to pass that on, and it’s about $2-$5 a day in cost. That’s something that our team has strived really hard for in the last 3 years to make possible and something we’ll continue to do in the future with the rest of our pipeline.

Related to this article

View more
Q&A: Caregiver burden can begin early in pet illness. Are veterinary teams equipped to support clients, and how can veterinary social workers help both parties?
Q&A: Caregiver burden can begin early in pet illness. Are veterinary teams equipped to support clients, and how can veterinary social workers help both parties?
Caroline Cox, LSW, MSW, and Erika Krick, VMD, DACVIM (Oncology), discuss the role of veterinary social workers in supporting clients, communicating with veterinary teams, and helping practices address the human side of veterinary care in this Q&A from an interview at the 2026 Fetch National Harbor Veterinary Conference.
Read more
Inside veterinary social work
Inside veterinary social work
In a slideshow drawn from an on-site dvm360 interview at the 2026 Fetch National Harbor Veterinary Conference, a veterinary oncologist and a veterinary social worker walk through how the role supports owners and staff across a pet's cancer diagnosis, treatment, and end-of-life care.
Read more
Laverdia now available for purchase for dogs with lymphoma
Laverdia now available for purchase for dogs with lymphoma
Verdinexor tablets are now available for dogs with lymphoma after receiving full FDA approval earlier this year, offering an at-home treatment option given twice weekly and showing a longer time to disease progression than the control in a field study.
Read more